Project 170533

Expanding the utility of hematopoietic stem cell products for vascular repair

170533

Expanding the utility of hematopoietic stem cell products for vascular repair

$300,000
Project Information
Study Type: Other Mechanistic_Study
Therapeutic Area: Cardiology
Research Theme: Clinical
Disease Area: ischemic injury, heart attacks, strokes, kidney failure
Data Type: Canadian
Institution & Funding
Principal Investigator(s): Allan, David S
Institution: Ottawa Hospital Research Institute
CIHR Institute: Circulatory and Respiratory Health
Program: CIHR New Investigator
Peer Review Committee: Health Professional Awards - New Investigators
Competition Year: 2008
Term: 5 yrs 0 mth
Abstract Summary

This research addresses the use of blood stem cell products to restore blood flow into damaged tissues. Blood stem cell products used for transplantation include bone marrow, peripheral blood stem cells, and umbilical cord blood. These blood products can also be transfused to assist in the repair of organ damage caused by disruptions in blood flow, termed ischemic injury. New blood vessel formation is a critical first step in the repair of ischemic tissue damage. The precise cells and proteins that are most critical for vascular repair are not fully understood and we plan to characterize specific cell subsets that are most enriched for the ability restore healthy vasculature into damaged tissues. Further, in this research, proteins will be identified that are central to the vascular repair process. An immunosuppressed mouse model will be used which accepts human cells. Specialized cells will be isolated and tested for their ability to form new blood vessels in the mice. This will allow for quantification and comparison of vascular function between specific cell populations from human umbilical cord blood, bone marrow, and peripheral blood stem cell products. Using an animal model for our experiments provides biological data that will be important for developing strategies that could be used in humans. Identifying proteins that are present in blood stem cell products with increased blood-forming function will allow us to characterize important signals associated with successful vascular regeneration. Biomarkers or signals will be critical for optimizing cellular regenerative therapy. Our work will provide a platform for developing cell therapy for the treatment of heart attacks, strokes, some types of kidney failure and some cases of trauma or accidents. The potential for widespread application of regenerative vascular therapy underscores the clinical importance of this emerging area and the possibility of a profound impact on the health of Canadians

Research Characteristics

This project includes the following research characteristics:

Regulatory Pathway
Biobank Use
Knowledge Translation Focus
Safety Focus
Biomarker Endpoints
Time to Event
Composite Endpoint
Dose Response
Personalized Medicine
Study Justification

"characterize specific cell subsets that are most enriched for the ability restore healthy vasculature into damaged tissues"

Novelty Statement

"identify proteins that are present in blood stem cell products with increased blood-forming function to characterize important signals associated with successful vascular regeneration"

Methodology Innovation

using immunosuppressed mouse model accepting human cells to quantify and compare vascular function between specific cell populations

Keywords
Blood And Marrow Transplantation Bone Marrow Nod/Scid Mouse Assay Regenerative Medicine Umbilical Cord Blood Vascular Progenitors